Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cetamolol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Epinephrine-induced hypokalemia is a beta 2-adrenoceptor-mediated effect known to occur in patients after acute myocardial… Expand
1988
1988
The objective of the present study was to compare the quantitative differences in the β1,- vs. β2-adrenoceptor affinity and… Expand
1988
1988
The effect of cetamolol (an investigational cardioselective beta blocker with intrinsic sympathomimetic activity) on the… Expand
1988
1988
The selectivity of the beta‐adrenoceptor blockade produced by single oral doses of cetamolol, atenolol, and nadolol was compared… Expand
1986
1986
We studied blood pressure (BP) and heart rate (HR) responses in 12 patients with hypertension who were receiving cetamolol, a… Expand
1985
1985
The cardiovascular effects of adimolol, a new, potent, long acting beta-adrenoceptor blocking drug were investigated in three… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
1985
1985
Cetamolol is a new beta-adrenoceptor blocking agent shown in animals to have moderate beta 1-adrenoceptor selectivity and partial… Expand
1984
1984
The cardiovascular effects of cetamolol, a new beta-adrenoceptor blocker, were studied in the anesthetized dog and cat and in the… Expand
1984
1984
Cetamolol, a new beta-adrenoceptor blocker with partial agonist activity and cardioselectivity, was studied in vivo to determine… Expand
1983
1983
In vitro studies on the new beta-adrenoceptor antagonist, cetamolol (Betacor), have demonstrated that the compound is a potent… Expand